Revenue decline — Reported net revenue fell to RMB 8,280,000 (USD 1,160,000) from RMB 24,740,000 in the same period of 2024, ...

Elutia Inc (ELUT) reports robust EluPro sales growth and strategic partnerships, but faces ongoing financial hurdles and ...

Despite achieving historic production levels, GreenFirst Forest Products Inc (ICLTF) faces financial hurdles due to increased ...

Q3 2025 Outlook -- Net sales are forecasted at $15.9 million for Q3 2025, representing year-over-year growth of approximately ...

Q2 2025 Earnings Call Transcript August 14, 2025 Operator: Ladies and gentlemen, thank you for standing by. Welcome to the ...

Q2 2025 Earnings Call Transcript August 14, 2025 Operator: Welcome, ladies and gentlemen, and thank you for your patience. You’ve joined Xunlei’s Second Quarter 2025 Earnings Conference Call.

Q2 2025 Earnings Conference Call August 14, 2025 10:00 AM ETCompany ParticipantsClaudia Goldfarb - Co-Founder, CEO ...

Q2 2025 Earnings Call Transcript August 14, 2025Brainstorm Cell Therapeutics Inc. beats earnings expectations.

Q2 2025 Earnings Conference Call August 14, 2025 5:00 PM ETCompany ParticipantsDomenic Della Penna - Executive VP ...

MiNK Therapeutics, Inc. (NASDAQ: INKT) Q2 2025 Earnings Call Transcript August 14, 2025 MiNK Therapeutics, Inc. misses on ...

Total Revenue-- $104,000,000 in total revenue (GAAP) for Q2 2025, reflecting 30.6% year-over-year growth mainly driven by increased revenue from major business operations. Subscription Revenue-- ...

License fee revenue increased 4% in Q2 2025, supported by a growing subscription contract base. Service Revenue-- Service revenue rose 11% in Q2 2025, mostly due to customer service activities for a ...